Literature DB >> 23084199

Heparin-binding epidermal growth factor-like growth factor promotes murine enteric nervous system development and enteric neural crest cell migration.

Yu Zhou1, Iyore James, Gail E Besner.   

Abstract

BACKGROUND/
PURPOSE: Developmental defects of the enteric nervous system lead to a variety of disorders including Hirschprung disease. We have previously shown that heparin-binding epidermal growth factor-like growth factor (HB-EGF) exerts neuroprotective effects on injured neurons. The goals of this study were to assess the role of HB-EGF in enteric nervous system development and to evaluate the effect of HB-EGF on enteric neural crest-derived cell (ENCC) migration in the developing gastrointestinal tract of mice.
MATERIALS AND METHODS: HB-EGF immunohistochemistry was used to examine HB-EGF protein expression in the hindgut of embryonic mice. Gut specimens were stained for PGP9.5 (a neuronal cell marker) to examine the extent of ENCC migration in the intestine at different embryonic stages in HB-EGF knockout (KO) and wild-type (WT) mice. Embryonic gut organ cultures were established to examine the effect of HB-EGF on ENCC migration.
RESULTS: The expression of HB-EGF was limited to the endodermal epithelium of the hindgut in early gestation, but rapidly involved the hindgut mesenchyme after ENCC migrated into this region. ENCC migration was significantly delayed in HB-EGF KO compared with WT embryos, leading to defects in neural colonization of the distal gut in postnatal HB-EGF KO mice. Addition of HB-EGF to WT embryonic intestine significantly promoted ENCC migration, as demonstrated by a significant increase in the ratio of ENCC migration distance toward the distal hindgut/total colon length (78% ± 4% vs 53% ± 2%, P = .001).
CONCLUSIONS: Deletion of the HB-EGF gene leads to enteric nervous system developmental defects. HB-EGF stimulates ENCC migration in the gut, supporting a potential role for administration of HB-EGF in the future for the treatment of patients with intestinal neuronal disorders.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23084199      PMCID: PMC3481188          DOI: 10.1016/j.jpedsurg.2012.05.008

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  36 in total

Review 1.  Embryology and development of the enteric nervous system.

Authors:  H M Young; C J Hearn; D F Newgreen
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4.

Authors:  J P Golding; P Trainor; R Krumlauf; M Gassmann
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

3.  Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness.

Authors:  Genevieve M Kruger; Jack T Mosher; Suzanne Bixby; Nancy Joseph; Toshihide Iwashita; Sean J Morrison
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

4.  The enteric nervous system.

Authors:  Valentina Sasselli; Vassilis Pachnis; Alan J Burns
Journal:  Dev Biol       Date:  2012-01-24       Impact factor: 3.582

5.  Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.

Authors:  Ryo Iwamoto; Satoru Yamazaki; Masanori Asakura; Seiji Takashima; Hidetoshi Hasuwa; Kenji Miyado; Satoshi Adachi; Masafumi Kitakaze; Koji Hashimoto; Gerhard Raab; Daisuke Nanba; Shigeki Higashiyama; Masatsugu Hori; Michael Klagsbrun; Eisuke Mekada
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-05       Impact factor: 11.205

6.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

7.  Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex.

Authors:  Jane Viti; Angela Feathers; Jennifer Phillips; Laura Lillien
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

8.  Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling.

Authors:  Leslie F Jackson; Ting Hu Qiu; Susan W Sunnarborg; Aileen Chang; Chunlian Zhang; Cam Patterson; David C Lee
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

9.  Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo.

Authors:  Kunlin Jin; Xiao Ou Mao; Yunjuan Sun; Lin Xie; Lan Jin; Eiichiro Nishi; Michael Klagsbrun; David A Greenberg
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  EGFRs mediate chemotactic migration in the developing telencephalon.

Authors:  D Caric; H Raphael; J Viti; A Feathers; D Wancio; L Lillien
Journal:  Development       Date:  2001-11       Impact factor: 6.868

View more
  4 in total

1.  Heparin-binding EGF-like growth factor promotes neuronal nitric oxide synthase expression and protects the enteric nervous system after necrotizing enterocolitis.

Authors:  Yu Zhou; Yijie Wang; Jacob Olson; Jixin Yang; Gail E Besner
Journal:  Pediatr Res       Date:  2017-05-24       Impact factor: 3.756

2.  Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis.

Authors:  Jegen Kandasamy; Shehzad Huda; Namasivayam Ambalavanan; Tamas Jilling
Journal:  Pathophysiology       Date:  2014-02-16

3.  Heparin-binding EGF-like growth factor and enteric neural stem cell transplantation in the prevention of experimental necrotizing enterocolitis in mice.

Authors:  Jia Wei; Yu Zhou; Gail E Besner
Journal:  Pediatr Res       Date:  2015-03-25       Impact factor: 3.756

4.  Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.

Authors:  Reagon Karki; Alpha Tom Kodamullil; Martin Hofmann-Apitius
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.